This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreens August Sales Increase 5.6 Percent

Walgreens (NYSE: WAG) (Nasdaq: WAG) had August sales of $6.17 billion, an increase of 5.6 percent from $5.84 billion for the same month in fiscal 2012.

Total front-end sales increased 3.9 percent compared with the same month in fiscal 2012, while comparable store front-end sales increased 2.2 percent. Customer traffic in comparable stores decreased 1.5 percent while basket size increased 3.7 percent.

Prescriptions filled at comparable stores increased by 5.6 percent in August and increased 7.4 percent on a calendar day-shift adjusted basis. This year’s August had one additional Saturday and one fewer Wednesday compared with August 2012. These calendar shifts negatively impacted prescriptions filled at comparable stores by 1.8 percentage points.

The company said the percentage of Express Scripts prescriptions returning to its pharmacies continued to increase in August.

August pharmacy sales increased by 6.4 percent, while comparable store pharmacy sales also increased 6.4 percent and increased by a calendar day-shift adjusted 8.2 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 1.8 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.3 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 64.3 percent of total sales for the month.

Sales in comparable stores increased by 4.8 percent in August. Calendar day shifts negatively impacted total comparable sales by 1.2 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 0.8 percentage point.

Registrations for Walgreens Balance ® Rewards loyalty program, which launched in September 2012, totaled more than 83 million through August.

Total sales for the fourth quarter of fiscal 2013, which ended Aug. 31, were $17.95 billion, up 5.1 percent from $17.07 billion in last year’s quarter. Comparable store sales for the fourth quarter of fiscal 2013 increased 4.5 percent (4.9 percent day-fall adjusted), while front-end comparable store sales for the quarter increased 1.7 percent. Prescriptions filled at comparable stores increased 6.8 percent in the fourth quarter (7.4 percent day-fall adjusted) and comparable pharmacy sales increased 6.2 percent (6.8 percent day-fall adjusted).

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs